摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ergothionein | 162240-56-4

中文名称
——
中文别名
——
英文名称
Ergothionein
英文别名
ergothioneine;5-[2-carboxy-2-(trimethylazaniumyl)ethyl]-1H-imidazole-2-thiolate
Ergothionein化学式
CAS
162240-56-4
化学式
C9H15N3O2S
mdl
——
分子量
229.303
InChiKey
SSISHJJTAXXQAX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    96.3
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    Ergothionein双氧水 作用下, 以 为溶剂, 生成 hercynine
    参考文献:
    名称:
    基于化学衍生氧化产物海西宁和进一步分解产物的麦角硫因抗氧化机制。
    摘要:
    麦角硫因 (ERGO) 是一种硫代组氨酸甜菜碱,存在于各种真菌、植物和动物中。人类从饮食中摄取 ERGO。ERGO 是一种强生物抗氧化剂,但关于其氧化还原机制的报道数量有限。本研究的目的是阐明 ERGO 的氧化机制。进行 ERGO 与化学氧化剂的反应。ERGO 的氧化产物通过核磁共振和液相色谱-质谱 (LC-MS) 进行分析。在生理条件下过氧化氢氧化 ERGO 的主要产物被鉴定为海西宁(组氨酸甜菜碱)。1 分子 ERGO 能够还原 2 分子过氧化氢。Hercynine 被发现与更有效的氧化剂次氯酸盐反应。LC-MS 检测到一种不稳定的分解产物。因此,
    DOI:
    10.1093/bbb/zbab006
  • 作为产物:
    描述:
    l-histidine methyl ester dihydrochloride 在 palladium on activated charcoal TEA 、 氢气碳酸氢钠三乙胺硫代氯甲酸苯酯 作用下, 以 四氢呋喃甲醇二氯甲烷 为溶剂, 10.0~60.0 ℃ 、506.62 kPa 条件下, 反应 97.5h, 生成 Ergothionein
    参考文献:
    名称:
    Synthesis of L-(+)-Ergothioneine
    摘要:
    The first synthesis of L-(+)-ergothioneine (1), a rare natural amino acid, is described. The key step is the direct transformation of the imidazole derivative 11 into imidazole-2-thione 12. This reaction consists of the cleavage and the re-formation of imidazole ring (ANRORC) with phenyl chlorothionoformate via a Bamberger-type intermediate. The conditions used are mild enough to preserve the asymmetric center at the a-carbon. The release of enantiomerically pure L-ergothioneine (1) from the ammonium derivative 15 was performed under acidic conditions to avoid the very easy racemization of the betaine function. An efficient and high-yield synthesis of 2-mercapto-L-histidine (2) which uses the new imidazole-2-thione formation reaction is also described.
    DOI:
    10.1021/jo00125a014
点击查看最新优质反应信息

文献信息

  • NOVEL SELENIUM-CONTAINING COMPOUNDS
    申请人:YAMASHITA Yumiko
    公开号:US20110178018A1
    公开(公告)日:2011-07-21
    A novel selenium-containing compound, a method of producing the selenium-containing compound, an analysis method using the selenium-containing compound, and use of the selenium-containing compound as an antioxidant, are disclosed. A novel selenium-containing compound shown by any of chemical formulas 1 to 4 is obtained by extracting a selenium-containing compound from a sample using an organic solvent or water, and purifying the selenium-containing compound. The novel selenium-containing compound may be used for a novel analysis method, or may be used as an antioxidant.
    揭示了一种新的含硒化合物,生产该含硒化合物的方法,使用该含硒化合物的分析方法,以及将该含硒化合物用作抗氧化剂的用途。通过使用有机溶剂或从样品中提取含硒化合物,并纯化含硒化合物,可以获得任何化学式1至4所示的一种新的含硒化合物。这种新的含硒化合物可以用于一种新的分析方法,也可以用作抗氧化剂
  • PROCESS FOR THE SYNTHESIS OF L-(+)-ERGOTHIONEINE
    申请人:Trampota Miroslav
    公开号:US20090093642A1
    公开(公告)日:2009-04-09
    This invention relates to a novel process for the preparation of optically pure L-(+)-ergothioneine. The process for the chemical synthesis of L-ergothioneine comprises steps which consist of reacting L-histidine alkyl ester with an acid halide, chloroformate or pyrocarbonate in the presence of a base, hydrolysis of the alkyl-(S,Z)-2,4,5-triamidopent-4-enoate to obtain a (S)-alkyl 2,5-diamido-4-oxopentanoate, acid catalyzed hydrolysis of the (S)-alkyl 2,5-diamido-4-oxopentanoate followed by reaction with a metal thiocyanate to obtain the thiohistidine, protection of the sulfur of thiohistidine as the tert-butyl thioether, dialkylation of the primary amine to obtain a tertiary amine, quaternization of the tertiary amine, and removal of the protecting group to obtain the desired (S)-3-(2-mercapto-1H-imidazol-5-yl)-2-(trialkylammonio)propanoate (I). This process affords a better yield and is capable of practical application at large scale.
    这项发明涉及一种制备光学纯L-(+)-麦角胺的新工艺。L-麦角胺的化学合成过程包括以下步骤:将L-组氨酸烷基酯与酸卤、氯甲酸酯或碳酸酯在碱的存在下反应,解烷基-(S,Z)-2,4,5-三基戊-4-烯酸酯以获得(S)-烷基2,5-二基-4-氧代戊酸酯,酸催化解(S)-烷基2,5-二基-4-氧代戊酸酯,然后与硫氰酸盐反应以获得酸,将酸的保护为叔丁基硫醚,对一级胺进行二烷基化以获得三级胺,对三级胺进行季化,去除保护基以获得所需的(S)-3-(2-巯基-1H-咪唑-5-基)-2-(三烷基)丙酸酯(I)。这个工艺提供了更好的产率,并且适用于大规模实际应用。
  • [EN] PROCESS FOR THE SYNTHESIS OF L-(+)-ERGOTHIONEINE<br/>[FR] PROCÉDÉ DE SYNTHÈSE DE LA L-(+)-ERGOTHIONÉINE
    申请人:PHARMATECH INTERNATIONAL INC
    公开号:WO2009045413A1
    公开(公告)日:2009-04-09
    This invention relates to a novel process for the preparation of optically pure L- (+)-ergothioneine. The process for the chemical synthesis of L-ergothioneine comprises steps which consist of reacting L-histidine alkyl ester with an acid halide, chloroformate or pyrocarbonate in the presence of a base, hydrolysis of the alkyl-(S,Z)-2,4,5- triamidopent-4-enoate to obtain a (S)-alkyl 2,5-diamido-4-oxopentanoate, acid catalyzed hydrolysis of the (S)-alkyl 2,5-diamido-4-oxopentanoate followed by reaction with a metal thiocyanate to obtain the thiohistidine, protection of the sulfur of ttiiohistidine as the te/f-butyl thioether, dialkylation of the primary amine to obtain a tertiary amine.quaternization of the tertiary amine, and removal of the protecting group to obtain the desired (S)-3-(2-mercapto-1 H-imidazol-5-yl)-2-(trialkylammonio)propanoate (l). This process affords a better yield and is capable of practical application at large scale.
    本发明涉及一种制备光学纯L-(+)-麦角酸的新工艺。该化学合成L-麦角酸的过程包括以下步骤:在碱的存在下,将L-组氨酸烷基酯与酸卤、氯甲酸酯或者碳酸酯反应,解烷基-(S,Z)-2,4,5-三酰基戊-4-烯酸酯以获得(S)-烷基2,5-二基-4-氧代戊酸酯,酸催化解(S)-烷基2,5-二基-4-氧代戊酸酯,然后与硫氰酸盐反应以获得麦角酸,将麦角酸的保护为对叔丁基硫醚,将一级胺进行二烷基化以获得三级胺,对三级胺进行季化,去除保护基以获得所需的(S)-3-(2-巯基-1 H-咪唑-5-基)-2-(三烷基)丙酸盐(l)。该工艺具有更好的产量,并且可以在大规模实际应用中使用。
  • Methods for Sterilizing Tissue
    申请人:Burgess Wilson
    公开号:US20110091353A1
    公开(公告)日:2011-04-21
    Methods are disclosed for sterilizing tissue to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria, (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. The methods involve sterilizing one or more tissues with irradiation.
    本发明揭示了用于灭菌组织以减少其中一个或多个活性生物污染物或病原体平的方法,例如病毒、细菌(包括细胞内和细胞外细菌,例如支原体、尿道支原体、纳米细菌、沙眼衣原体、立克次体)、酵母菌、霉菌、真菌、朊病毒或类似的单独或组合的代理人,对于TSEs和/或单个或多细胞寄生虫负责。该方法涉及使用辐照灭菌一个或多个组织。
  • Ergothioneine production through metabolic engineering
    申请人:Liu Pinghua
    公开号:US10167490B2
    公开(公告)日:2019-01-01
    The present disclosure relates to the production of ergothioneine through either in vitro enzymatic transformations or fermentations using microbials created by metabolic engineering. Also disclosed are transformed cells useful in such methods and ergothioneine produced by such methods. Transformed cells of the disclosure are capable of converting histidine and cysteine or hercynine and cysteine into ergothioneine in greater efficiency than the untransformed wild-type cells.
    本公开涉及通过体外酶转化或利用代谢工程微生物发酵生产麦角硫因。还公开了用于这种方法的转化细胞和用这种方法生产的麦角硫因。与未转化的野生型细胞相比,本发明公开的转化细胞能够以更高的效率将组酸和半胱酸或 hercynine 和半胱酸转化为麦角硫因
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸